SAM.govNOI-PCA-NIDA-09054
Open
Pharmacogenomic Analysis of Participants Enrolled in the STAR-B Randomized Clinical Trial of Semaglutide for Alcohol Use Disorder
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · Maryland
- Response deadline
- Sep 15, 2026 Closed
- Date posted
- Sep 8, 2026
- Source
- Open notice
Description
Please see the attached Notice of Intent titled NOI-PCA-NIDA-09054 and Statement of Work.
Classifications
Documents (2)
- NOI-PCA-NIDA-09054.pdf.pdf186 KBNot yet available
- SOW PCA-NIDA-09054.pdf.pdf143 KBNot yet available
Contacts
- zachary.fetters@nih.gov2402369291
- ashley.kinderdine@nih.gov2406695154
Similar contracts
- Annual Medical Gas Testing Pop: 11/20/2026 - 11/19/2031CADue Nov 9, 2026
- Notice of Intent to Sole-Source Requirement: Artera AI Prostate Exam Testing - Cleveland VAMCOhioDue Nov 10, 2026
- Sterile Compounding ServicesTexasDue Nov 17, 2026
- ORSC Certification and Testing ContractMarylandDue Nov 15, 2026
- Laboratory Analysis of Water SamplesDue Dec 2, 2026
- Media Fill Testing for Clean Room Compliance - Pharmacy Base 4 yearsDue Nov 4, 2026